Fuisz Technologies to develop in-house OTCs and dietary supplement products.
This article was originally published in The Tan Sheet
Executive Summary
FUISZ HOPES TO BEGIN MARKETING IN-HOUSE OTC ANALGESICS, SUPPLEMENTS in early 1997. An OTC analgesic product using Fuisz Technologies' drug-delivery technology will be followed by calcium supplements and an OTC H2 antagonist. Fuisz announced plans Aug. 15 to expand its business beyond the development of drug delivery and food applications for other companies' products into the development of its own OTC products.